Medcolcanna Organics Inc. Share Price Toronto S.E.
Equities
MCCN
CA58406X1050
Pharmaceuticals
Sales 2019 | 1.58K 1.16K 92.21K | Sales 2020 | 95.77K 70.02K 5.58M | Capitalization | 8.09M 5.91M 471M |
---|---|---|---|---|---|
Net income 2019 | -7M -5.12M -408M | Net income 2020 | -7M -5.12M -408M | EV / Sales 2019 | 4,531 x |
Net cash position 2019 | 2.32M 1.7M 135M | Net Debt 2020 | 2.98M 2.18M 174M | EV / Sales 2020 | 116 x |
P/E ratio 2019 |
-1.04
x | P/E ratio 2020 |
-1
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 41.37% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | 16/05/19 | |
Christopher Reid
DFI | Director of Finance/CFO | 46 | 16/05/19 |
Ana María Borda
CTO | Chief Tech/Sci/R&D Officer | - | 31/03/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Metcalfe
CHM | Chairman | 84 | 16/05/19 |
Christopher Reid
DFI | Director of Finance/CFO | 46 | 16/05/19 |
Chief Executive Officer | 44 | 16/05/19 |
1st Jan change | Capi. | |
---|---|---|
+43.92% | 4.18B | |
+144.67% | 2.28B | |
+122.22% | 67.89M |